Cortef and Megace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cortef (hydrocortisone) and Megace (megestrol acetate). Common drug interactions include abdominal pain among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Cortef and Megace. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Cortef?

Cortef has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 4,254 Cortef users. Check the latest studies of Cortef.

What is Megace?

Megace has active ingredients of megestrol acetate. It is often used in weight loss. eHealthMe is studying from 10,095 Megace users. Check the latest studies of Megace.



On Aug, 08, 2026

20 people who take Cortef and Megace together, and have interactions are studied.

Cortef and Megace drug interactions.

What are the common drug interactions of Cortef and Megace, by gender? *:

female:

  1. Abdominal pain
  2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  3. Nausea (feeling of having an urge to vomit)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Fall
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Septic shock (shock due to blood infection)
  9. Vomiting
  10. Cardiac failure acute

male:

  1. Fatigue (feeling of tiredness)
  2. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  3. Hyperbilirubinaemia (excess of bilirubin in the blood)
  4. Hypotension (abnormally low blood pressure)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Impaired healing
  7. Lactic acidosis (low ph in body tissues)
  8. Renal cell carcinoma (a kidney cancer)
  9. Respiratory disorder (respiratory disease)
  10. Secondary adrenocortical insufficiency (inadequate secretion of acth by the pituitary gland)

What are the common drug interactions of Cortef and Megace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

20-29:

  1. Gait disturbance

30-39:

  1. Confusional state
  2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Abdominal pain
  5. Nausea (feeling of having an urge to vomit)
  6. Septic shock (shock due to blood infection)
  7. Vomiting
  8. Cardiac failure acute
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

40-49:

n/a

50-59:

  1. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  2. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  3. Nausea (feeling of having an urge to vomit)
  4. Neuropathy peripheral (surface nerve damage)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  7. Oedema (fluid collection in tissue)
  8. Orbital oedema (swelling of orbit)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

60+:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Coagulopathy (blood's ability to clot is impaired)
  3. Impaired healing
  4. Lactic acidosis (low ph in body tissues)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Renal cell carcinoma (a kidney cancer)
  7. Secondary adrenocortical insufficiency (inadequate secretion of acth by the pituitary gland)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
  10. Acute pulmonary oedema (sudden deposit of fluid in the lung))

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 5 people, 25.00%
  2. Nausea And Vomiting: 4 people, 20.00%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 15.00%
  4. Dry Eyes (lack of adequate tears): 3 people, 15.00%
  5. Diarrhea: 3 people, 15.00%
  6. Pain: 3 people, 15.00%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 15.00%
  8. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 3 people, 15.00%
  9. Stress And Anxiety: 3 people, 15.00%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cortef and Megace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cortef and Megace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Megace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Megace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone and megestrol acetate (the active ingredients of Cortef and Megace, respectively), and Cortef and Megace (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: